As of Sep 28, 2023, the Iqvia Holdings stock's PE ratio is 33.4. This takes into account the latest EPS of $5.92 and stock price of $197.7. The PE ratio marks a decrease of 2.6% from its last 4 quarters average of 34.3.
The PE ratio of Iqvia Holdings has averaged 164.92 over the last ten years. The current P/E ratio of 33.4 is 80% lower than the historical average. Looking back at the last ten years, IQV's PE ratio peaked in the Mar 2017 quarter at 4,026.5, when the price was $80.53 and the EPS was $0.02. The lowest point was in the Dec 2017 quarter, when it reached 16.71 with a price of $97.9 and an EPS of $5.86.
Maximum annual increase: 626.79% in 2016
Maximum annual decrease: -89.45% in 2017
IQV's current PE ratio is lower than its 3, 5 and 10-year averages.
IQV's PE ratio stands lower than its peer stock NRC.
|Stock name||PE ratio||Market cap|
|IQV Iqvia Holdings Inc||33.56||$36.39B|
|NRC National Research Corp||37.34||$1.09B|
|NWBO Northwest Biotherapeutics Inc||N/A||$975.33M|
The price to earnings ratio for IQV stock as of Sep 28, 2023, stands at 33.4.
Over the last 3 years, the average price to earnings ratio for IQV stock is 65.7.
Over the last 5 years, the average price to earnings ratio for IQV stock is 86.52.
Over the last ten years, the Mar 2017 quarter recorded the highest quarterly PE ratio at 4,026.5.
IQV's price to earnings ratio is currently 80% below its 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Sep 28, 2023), Iqvia Holdings's share price is $197.7. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2023 is $5.92. Therefore, Iqvia Holdings's PE ratio for today is 33.4.
PE RATIO(33.4) = STOCK PRICE($197.7) / TTM EPS($5.92)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.